Mustang Bio, Inc.
MBIO
$1.54
-$0.11-6.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.78% | 73.28% | 69.47% | 62.61% | 55.19% |
| Total Depreciation and Amortization | -88.30% | -91.86% | -63.01% | -58.79% | -54.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | 7.89% | 23.97% | 24.66% | -31.38% | -77.91% |
| Change in Net Operating Assets | -283.81% | 89.91% | 102.72% | 325.67% | 98.43% |
| Cash from Operations | 75.93% | 79.78% | 76.94% | 71.02% | 56.14% |
| Capital Expenditure | -- | -- | -- | 76.74% | 97.29% |
| Sale of Property, Plant, and Equipment | -80.58% | -80.58% | -- | -100.00% | 4,624.41% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 86.30% |
| Cash from Investing | -80.32% | -80.21% | -- | -100.55% | 539.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 43.90% | 309.50% | 154.06% | 3,080.12% | 1,006.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -74.16% | -74.16% | -74.16% | -19,600.00% | -3,608.33% |
| Cash from Financing | 40.02% | 172.34% | 143.19% | 134.24% | 132.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 169.74% | 121.91% | 99.79% | 92.19% | 87.54% |